FINV
FINAL DECISION TRANSACTION PROCESSED BY IB
01/02/2023
Voltar para busca
Dado oficial do USPTO
C
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
32
Atualização mais recente
01/02/2023
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5
Data de depósito
07/07/2021
Data de registro
20/09/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
20/09/2022
Última transação
20/09/2022
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
99
Localização do titular
CH
Examinador
LAPTER, ALAIN
Unidade examinadora
L50
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of a backward "C" composed of seven conjoined, partially overlapping circles; the color grey is intended to show shading or contrast only and is not a feature of the mark.
Titulares e representantes
Titulares
NOVARTIS AG
Representantes
Maury M. Tepper, III Tepper & Eyster, PLLC
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune systemthe metabolic systemthe endocrine systemthe musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
Publicações
Histórico de despachos e eventos da marca no USPTO.
32 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/01/2023
FIMP
FINAL DISPOSITION PROCESSED
11/01/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
20/12/2022
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
20/09/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
20/09/2022
GPNX
NOTIFICATION PROCESSED BY IB
19/07/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/07/2022
PUBO
PUBLISHED FOR OPPOSITION
05/07/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
29/06/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
29/06/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
15/06/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
30/05/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
23/05/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
23/05/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
23/05/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/05/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/05/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
01/05/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/05/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/05/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/05/2022
RFNT
REFUSAL PROCESSED BY IB
08/03/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
15/02/2022
RFRR
REFUSAL PROCESSED BY MPU
15/02/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
25/01/2022
CNRT
NON-FINAL ACTION WRITTEN
24/01/2022
DOCK
ASSIGNED TO EXAMINER
21/01/2022
MAFR
APPLICATION FILING RECEIPT MAILED
26/10/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
22/10/2021
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
20/10/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/10/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace C ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.